Cancer treatment

Cancer research

Breakthrough in Cancer Gene Therapy: Hyaluronic Acid-Modified Epigallocatechin Gallate Nanoliposomes Show Promise

Researchers from Shenyang Pharmaceutical University have made a significant discovery in the field of cancer gene therapy, developing a novel hyaluronic acid (HA)-modified epigallocatechin gallate (EGCG)-loaded liposome that enhances stability and anticancer efficacy against A549 cells. The study, published in Carbohydrate Polymer Technologies and Applications, found that the